The Impaired Wound Healing Process Is a Major Factor in Remodeling of the Corneal Epithelium in Adult and Adolescent Patients With Keratoconus.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 02 2023
01 02 2023
Historique:
entrez:
22
2
2023
pubmed:
23
2
2023
medline:
25
2
2023
Statut:
ppublish
Résumé
Keratoconus (KTCN) is the most common corneal ectasia, characterized by pathological cone formation. Here, to provide an insight into the remodeling of the corneal epithelium (CE) during the course of the disease, we evaluated topographic regions of the CE of adult and adolescent patients with KTCN. The CE samples from 17 adult and 6 adolescent patients with KTCN, and 5 control CE samples were obtained during the CXL and PRK procedures, respectively. Three topographic regions, central, middle, and peripheral, were separated toward RNA sequencing and MALDI-TOF/TOF Tandem Mass Spectrometry. Data from transcriptomic and proteomic investigations were consolidated with the morphological and clinical findings. The critical elements of the wound healing process, epithelial-mesenchymal transition, cell-cell communications, and cell-extracellular matrix interactions were altered in the particular corneal topographic regions. Abnormalities in pathways of neutrophils degranulation, extracellular matrix processing, apical junctions, IL, and IFN signaling were revealed to cooperatively disorganize the epithelial healing. Deregulation of the epithelial healing, G2M checkpoints, apoptosis, and DNA repair pathways in the middle CE topographic region in KTCN explains the presence of morphological changes in the corresponding doughnut pattern (a thin cone center surrounded by a thickened annulus). Despite similar morphological characteristics of CE samples in adolescents and adults with KTCN, their transcriptomic features were different. Values of the posterior corneal elevation differentiated adults with KTCN from adolescents with KTCN and correlated with the expression of TCHP, SPATA13, CNOT3, WNK1, TGFB2, and KRT12 genes. Identified molecular, morphological, and clinical features indicate the effect of impaired wound healing on corneal remodeling in KTCN CE.
Identifiants
pubmed: 36811882
pii: 2785390
doi: 10.1167/iovs.64.2.22
pmc: PMC9970004
doi:
Substances chimiques
Cross-Linking Reagents
0
CNOT3 protein, human
0
Transcription Factors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
22Références
PLoS Genet. 2020 Apr 27;16(4):e1008721
pubmed: 32339198
Ophthalmology. 2008 Sep;115(9):1534-9
pubmed: 18405974
Ocul Surf. 2020 Jul;18(3):363-373
pubmed: 32234342
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Ophthalmic Res. 2021;64(2):178-191
pubmed: 32474566
Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2977-2986
pubmed: 30029277
Bioinformatics. 2015 Jun 15;31(12):2032-4
pubmed: 25697820
J Refract Surg. 2010 Apr;26(4):259-71
pubmed: 20415322
Cell Death Dis. 2012 Feb 23;3:e273
pubmed: 22361748
Ophthalmic Physiol Opt. 2013 Mar;33(2):78-93
pubmed: 23406488
Eur J Ophthalmol. 2017 Mar 10;27(2):129-134
pubmed: 27515569
Int J Ophthalmol. 2017 Nov 18;10(11):1640-1646
pubmed: 29181305
Ophthalmic Res. 2019;62(3):134-140
pubmed: 31266046
Cytotechnology. 2020 Apr;72(2):239-245
pubmed: 32016711
Cont Lens Anterior Eye. 2007 Sep;30(4):223-32
pubmed: 17481941
FASEB J. 2010 Mar;24(3):769-77
pubmed: 19901020
Exp Eye Res. 2015 Jun;135:109-17
pubmed: 25682729
Crit Rev Biochem Mol Biol. 2012 Jul-Aug;47(4):315-33
pubmed: 22416820
Am J Ophthalmol. 2003 May;135(5):620-7
pubmed: 12719068
Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9816-21
pubmed: 27540116
JAMA Ophthalmol. 2016 Feb;134(2):167-73
pubmed: 26633035
PLoS One. 2012;7(1):e29611
pubmed: 22253744
J Cell Biol. 1998 Apr 20;141(2):515-26
pubmed: 9548728
Lab Invest. 2021 Jun;101(6):690-700
pubmed: 33782532
Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1501-1509
pubmed: 30994860
Oncol Lett. 2017 May;13(5):3889-3895
pubmed: 28521486
Nucleic Acids Res. 2022 Jan 7;50(D1):D701-D709
pubmed: 34634810
Invest Ophthalmol Vis Sci. 2014 Dec 02;55(12):8371-6
pubmed: 25468892
Ocul Surf. 2021 Jul;21:279-298
pubmed: 33865984
Sci Rep. 2021 Oct 22;11(1):20891
pubmed: 34686755
Nucleic Acids Res. 2022 Jan 7;50(D1):D687-D692
pubmed: 34788843
Exp Eye Res. 2018 Nov;176:235-242
pubmed: 30193807
J Refract Surg. 2013 Mar;29(3):173-9
pubmed: 23446013
Am J Ophthalmol. 2017 Mar;175:169-172
pubmed: 28039037
Nat Genet. 2014 Aug;46(8):912-918
pubmed: 25017105
Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5372-5382
pubmed: 27732724
Immune Netw. 2015 Dec;15(6):291-303
pubmed: 26770183
Ophthalmol Ther. 2018 Dec;7(2):263-292
pubmed: 30191404
Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4237-46
pubmed: 14507867
Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):27
pubmed: 32790859
Int Ophthalmol. 2018 Jun;38(3):1147-1154
pubmed: 28551832
Pathology. 2012 Apr;44(3):234-9
pubmed: 22406479
NPJ Regen Med. 2021 Mar 26;6(1):16
pubmed: 33772031
Am J Ophthalmol. 2018 May;189:47-54
pubmed: 29458037
J Tissue Eng Regen Med. 2019 Sep;13(9):1595-1608
pubmed: 31207112
Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4492-9
pubmed: 20357207
Invest Ophthalmol Vis Sci. 2002 May;43(5):1422-8
pubmed: 11980856
JAMA Ophthalmol. 2015 Apr;133(4):480-2
pubmed: 25611213
Endocrinology. 2011 Jul;152(7):2690-703
pubmed: 21540282
Med Hypothesis Discov Innov Ophthalmol. 2018 Spring;7(1):1-9
pubmed: 29644238
Drug Discov Today. 2019 Feb;24(2):403-416
pubmed: 30408528
J Refract Surg. 2018 Jan 1;34(1):59-64
pubmed: 29315443
OMICS. 2019 Nov;23(11):583-597
pubmed: 31651220
Mol Vis. 2015 May 21;21:577-88
pubmed: 26015770
Graefes Arch Clin Exp Ophthalmol. 2020 Mar;258(3):565-575
pubmed: 31927639
Exp Eye Res. 2021 Jan;202:108398
pubmed: 33316263
Acta Ophthalmol. 2014 May;92(3):e170-84
pubmed: 23819758
Mol Vis. 2009 Dec 03;15:2554-69
pubmed: 20011627
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Int J Mol Sci. 2021 Nov 17;22(22):
pubmed: 34830308
PeerJ. 2020 Apr 14;8:e8982
pubmed: 32328353
Mol Genet Genomics. 2017 Apr;292(2):251-269
pubmed: 28032277
Nucleic Acids Res. 2020 Jan 8;48(D1):D504-D510
pubmed: 31665520
Cornea. 2020 Feb;39(2):263-270
pubmed: 31498247
Br J Ophthalmol. 2017 Jun;101(6):845-850
pubmed: 28416495
J Refract Surg. 2014 Jul;30(7):454-60
pubmed: 24892379
Invest Ophthalmol Vis Sci. 1997 Jan;38(1):121-9
pubmed: 9008637
Sci Rep. 2019 Feb 27;9(1):2965
pubmed: 30814630
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
Open Ophthalmol J. 2017 Jul 31;11:201-210
pubmed: 28932336
Int J Ophthalmol. 2019 Nov 18;12(11):1775-1781
pubmed: 31741868
Exp Eye Res. 2017 Jun;159:40-48
pubmed: 28315339
PLoS One. 2011 Jan 27;6(1):e16437
pubmed: 21298010
Curr Opin Ophthalmol. 2006 Aug;17(4):356-60
pubmed: 16900027
Surv Ophthalmol. 2017 Nov - Dec;62(6):770-783
pubmed: 28688894
Int J Ophthalmol. 2019 Dec 18;12(12):1929-1938
pubmed: 31850179
Cytokine. 2017 Oct;98:97-106
pubmed: 28094206
Klin Oczna. 1989 Jul-Sep;91(7-9):208-9
pubmed: 2638448
J Refract Surg. 2015 Nov;31(11):736-44
pubmed: 26544561
PLoS One. 2011 Feb 16;6(2):e17218
pubmed: 21359179
Cornea. 2020 Aug;39(8):946-951
pubmed: 32355111
Eur J Hum Genet. 2017 May;25(5):582-590
pubmed: 28145428
PeerJ. 2020 Aug 20;8:e9793
pubmed: 32879808
Acta Pharmacol Sin. 2015 Jan;36(1):24-31
pubmed: 25500870
Exp Eye Res. 2011 Jan;92(1):4-9
pubmed: 21056036
Sci Rep. 2018 Jan 10;8(1):389
pubmed: 29321650
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426
pubmed: 30407594
Cornea. 2015 Apr;34(4):359-69
pubmed: 25738235
J Refract Surg. 2012 Nov;28(11):753-8
pubmed: 23347367
J Cell Physiol. 2022 Jun;237(6):2703-2712
pubmed: 35147977
Curr Protoc Bioinformatics. 2004 Oct;Chapter 8:Unit 8.7
pubmed: 18428737
Indian J Ophthalmol. 2018 Feb;66(2):190-194
pubmed: 29380756
J Cataract Refract Surg. 2008 May;34(5):796-801
pubmed: 18471635
Ocul Surf. 2013 Apr;11(2):93-108
pubmed: 23583044
Sci Rep. 2021 Jun 7;11(1):11971
pubmed: 34099765
Nucleic Acids Res. 2020 Jan 8;48(D1):D489-D497
pubmed: 31647099
Nucleic Acids Res. 2012 Sep 1;40(17):e133
pubmed: 22638577